Outcome and Complications in Postcardiotomy Cardiogenic Shock Treated with Extracorporeal Life Support - a Systematic Review and Meta-analysis

Overview

Journal BMC Anesthesiol

Publisher Biomed Central

Date 2025 Jan 17

PMID 39825250

Authors

Romana Maria Kienlein

Ralf Felix Trauzeddel

Nilufar Akbari

Leonello Avalli

Fausto Biancari

Carlotta Sorini Dini

Sabina Guenther

Christian Hagl

Matthias Heringlake

Jochen Kruppa

Timo Makikallio

Raphael Martins

Marc Pineton De Chambrun

Ardawan Julian Rastan

Antonio Rubino

Floris van den Brink

Michael Nordine

Sascha Treskatsch

Affiliations

Soon will be listed here.

Abstract

Background: Postcardiotomy cardiogenic shock (PCCS) in cardiac surgery is associated with a high rate of morbidity and mortality. Beside other therapeutic measures (e.g. intraaortic balloon pump (IABP)), extracorporeal life support is being increasingly used in this particular form of shock. Objectives of this meta-analysis were to determine mortality and complications of extracorporeal life support treatment (ECLS) in cardiac surgery patients, and if outcomes were influenced by a preexisting cardiovascular risk profile.

Methods: MEDLINE and EMBASE were searched for studies in English, published between January 1 2000 and January 16 2023, reporting mortality and morbidity in patients aged ≥ 18 treated with ECLS for PCCS. Supplementary data were requested from the respective corresponding authors. Outcomes were weaning from extracorporeal life support, hospital survival and complications.

Results: Two thousand, seven hundred seventy-four papers were screened, of which 132 full text articles were assessed for suitability. 70 remaining studies were included for further evaluation and data analysis. Five studies could be included in the final analysis since the corresponding authors provided additional necessary information. Successful weaning from extracorporeal life support was accomplished in 52.8% (30.8%-57.4%) and 31.1% were discharged alive (mortality of 25.0 - 56.2% after weaning). 95.1% of all treated patients suffered from at least one complication. Diabetes mellitus and obesity seem to be independent risk factors for poor outcome.

Conclusions: Extracorporeal life support for PCCS is associated with a substantial mortality and complication rate. Diabetes mellitus and obesity seem to be independent risk factors. Therefore, until future work has elucidated which patients benefit at all, the risks of ECLS-treatment must be critically weighed up against a possible benefit.

References

Assmann A, Beckmann A, Schmid C, Werdan K, Michels G, Miera O . Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice Guideline Level 3. ESC Heart Fail. 2021; 9(1):506-518. PMC: 8788014. DOI: 10.1002/ehf2.13718. View

Fernando S, MacLaren G, Barbaro R, Mathew R, Munshi L, Madahar P . Age and associated outcomes among patients receiving venoarterial extracorporeal membrane oxygenation-analysis of the Extracorporeal Life Support Organization registry. Intensive Care Med. 2023; 49(12):1456-1466. DOI: 10.1007/s00134-023-07199-1. View

Zeymer U, Freund A, Hochadel M, Ostadal P, Belohlavek J, Rokyta R . Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials. Lancet. 2023; 402(10410):1338-1346. DOI: 10.1016/S0140-6736(23)01607-0. View

Fukuhara S, Takeda K, Garan A, Kurlansky P, Hastie J, Naka Y . Contemporary mechanical circulatory support therapy for postcardiotomy shock. Gen Thorac Cardiovasc Surg. 2016; 64(4):183-91. DOI: 10.1007/s11748-016-0625-4. View

Broman L, Taccone F, Lorusso R, Malfertheiner M, Pappalardo F, Di Nardo M . The ELSO Maastricht Treaty for ECLS Nomenclature: abbreviations for cannulation configuration in extracorporeal life support - a position paper of the Extracorporeal Life Support Organization. Crit Care. 2019; 23(1):36. PMC: 6367794. DOI: 10.1186/s13054-019-2334-8. View

Khorsandi M, Dougherty S, Bouamra O, Pai V, Curry P, Tsui S . Extra-corporeal membrane oxygenation for refractory cardiogenic shock after adult cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Surg. 2017; 12(1):55. PMC: 5512816. DOI: 10.1186/s13019-017-0618-0. View

Rubino A, Costanzo D, Stanszus D, Valchanov K, Jenkins D, Sertic F . Central Veno-Arterial Extracorporeal Membrane Oxygenation (C-VA-ECMO) After Cardiothoracic Surgery: A Single-Center Experience. J Cardiothorac Vasc Anesth. 2018; 32(3):1169-1174. DOI: 10.1053/j.jvca.2017.12.003. View

Avalli L, Sangalli F, Migliari M, Maggioni E, Gallieri S, Segramora V . Early vascular complications after percutaneous cannulation for extracorporeal membrane oxygenation for cardiac assist. Minerva Anestesiol. 2015; 82(1):36-43. View

Biancari F, Dalen M, Fiore A, Ruggieri V, Saeed D, Jonsson K . Multicenter study on postcardiotomy venoarterial extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 2019; 159(5):1844-1854.e6. DOI: 10.1016/j.jtcvs.2019.06.039. View

10.

Dodoo S, Kwapong Y, Agyemang-Sarpong A, Amoran E, Egolum U, Ghasemzadeh N . Comparative Healthcare Resource Utilization of Percutaneous Mechanical Circulatory Support Using Impella Versus Intra-aortic Balloon Pump Use for Patients With Acute Coronary Syndrome and Cardiogenic Shock Undergoing Percutaneous Coronary.... Curr Probl Cardiol. 2023; 49(1 Pt A):102053. DOI: 10.1016/j.cpcardiol.2023.102053. View

11.

van den Brink F, van Tooren R, Sonker U, Klein P, Waanders F, Zivelonghi C . Veno arterial-extra corporal membrane oxygenation for the treatment of cardiac failure in patients with infective endocarditis. Perfusion. 2019; 34(7):613-617. DOI: 10.1177/0267659119842807. View

12.

Thiele H, Jobs A, Ouweneel D, Henriques J, Seyfarth M, Desch S . Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. Eur Heart J. 2017; 38(47):3523-3531. DOI: 10.1093/eurheartj/ehx363. View

13.

Jain P, Salama M, Everett K, Reyelt L, Kapur N . To Vent or Not to Vent: A Loaded Question During Venoarterial Extracorporeal Membrane Oxygenation Support for Cardiogenic Shock. Circ Cardiovasc Interv. 2021; 14(5):e010537. DOI: 10.1161/CIRCINTERVENTIONS.121.010537. View

14.

Dunser M, Mayr A, Ulmer H, Ritsch N, Knotzer H, Pajk W . The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg. 2001; 93(1):7-13. DOI: 10.1097/00000539-200107000-00003. View

15.

Corujo Rodriguez A, Richter E, Ibekwe S, Shah T, Faloye A . Postcardiotomy Shock Syndrome: A Narrative Review of Perioperative Diagnosis and Management. J Cardiothorac Vasc Anesth. 2023; 37(12):2621-2633. DOI: 10.1053/j.jvca.2023.09.011. View

16.

Akbik B, Chou L, Gorthi J . Extracorporeal Membrane Oxygenation in Postcardiotomy Cardiogenic Shock. Methodist Debakey Cardiovasc J. 2023; 19(4):66-73. PMC: 10402824. DOI: 10.14797/mdcvj.1256. View

17.

De Chambrun M, Brechot N, Lebreton G, Schmidt M, Hekimian G, Demondion P . Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock post-cardiac arrest. Intensive Care Med. 2016; 42(12):1999-2007. DOI: 10.1007/s00134-016-4541-y. View

18.

de Waha S, Fuernau G, Eitel I, Desch S, Thiele H . Long-term prognosis after extracorporeal life support in refractory cardiogenic shock - results from a real-world cohort. EuroIntervention. 2016; 12(3):414. DOI: 10.4244/EIJV12I3A71. View

19.

Kowalewski M, Raffa G, Zielinski K, Meani P, Alanazi M, Gilbers M . Baseline surgical status and short-term mortality after extracorporeal membrane oxygenation for post-cardiotomy shock: a meta-analysis. Perfusion. 2019; 35(3):246-254. DOI: 10.1177/0267659119865122. View

20.

Wang L, Wang H, Hou X . Clinical Outcomes of Adult Patients Who Receive Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock: A Systematic Review and Meta-Analysis. J Cardiothorac Vasc Anesth. 2018; 32(5):2087-2093. DOI: 10.1053/j.jvca.2018.03.016. View